Gadolinium-based contrast agents

Gadolinium-based contrast agents

Burg Simpson is not currently pursuing new Gadolinium-based contrast agents cases.

If you have received a positive diagnosis for Nephrogenic Systemic Fibrosis (NSF), you should contact an NSF attorney as soon as possible. NSF can be a horrible disease and you may be entitled to some compensation for your pain and suffering.

Burg Simpson attorneys have played a key role in this litigation, obtaining recoveries on behalf of more than 150 people who suffered from NSF after exposure to a GBCA. Settlements obtained by Burg Simpson have been with the manufacturers of three different GBCAs and have resulted in significant improvement in the lives of our clients. Burg Simpson continues to represent victims of this awful disease.

Senior shareholder, Peter W. Burg, was appointed as Co-chair of the Plaintiffs’ Steering Committee and the Executive Committee for the Gadolinium-Based Contrast Agents Product Liability Multi District Litigation in the Northern District of Ohio by federal judge Honorable Dan A. Polster. Fellow Burg Simpson shareholder, Seth A. Katz, was appointed co-Chair of the litigation’s Discovery Committee.

SYMPTOMS OF NSF

Some side effects noticed early on are mild to moderate headaches, nausea and dizziness. The most visible symptom is a hardening of the skin, usually on the lower legs at first, then on the arms with the possibility to appear on other areas of the body. There may also be:

    • Red or darkened patches on the skin
    • Itching or burning sensations on the skin
    • Yellow areas in the whites of the eyes
    • Joint stiffness, making it hard to straighten the limbs, hands or feet
    • Muscle weakness
    • Bone pain in the hips or ribs

If you have noticed any of these symptoms, are under medical care for kidney impairment, and have had any MRI (Magnetic Resonance Imaging) or MRAs (Magnetic Resonance Angiogram) with a gadolinium-based contrast agent (GBCA), you may have developed NSF. We urge you to contact your doctor for testing, perhaps including a skin biopsy.

CONNECTION TO IMAGING DYES

Since NSF has only been known to occur for about ten years, it seems likely that it is related to some new agent used in medical diagnosis, or a new examination technique. (In fact, Gadolinium is the preferred contrast agent for patients with kidney disease.) NSF is strongly related to the use of gadolinium dyes for MRI/MRA scans.

Omniscan was approved by the FDA in 1993 and is used to provide visual contrast between normal and abnormal tissue in the central nervous system (brain, spinal cord, and spinal nerves). It is injected into the body before MRIs or MRAs are performed.

KIDNEY FUNCTION

Gadolinium is excreted from the body via the kidneys, and should therefore be used very cautiously in patients who already have renal problems. As it goes through the kidney tissue, it can have the same hardening effect that it has on the skin. This interferes with kidney function where fluids are filtered before they are stored in the bladder for excretion. This filtering action is crucial for health. It divides nutritious substances from toxins, sending toxins and waste products out of the body and retaining nutritious substances for health maintenance.

WHO IS SUSCEPTIBLE TO NSF?

So far, it has only been found in patients with either acute or long-standing and severe kidney impairment. No evidence has been found connecting it with patients with normal kidney function. If you have chronic kidney disease, you may have been given Gadolinium before an MRI or MRA, perhaps before many such imaging procedures. We would urge you to contact your physician and inquire about gadolinium and its side effects. Your physician can run tests including a skin biopsy to diagnose NSF.

SCIENTIFIC RESEARCH

Burg Simpson Eldredge Hersh & Jardine, P.C. has donated a potion of its attorney’s fees in the case to an independent, non-profit group that is studying this disease in the hope of finding a cure or more effective treatment for victims of NSF.

If you have NSF, you should call or email an attorney immediately. Burg Simpson represented numerous consumers injured by this product and resolved all of their claims via settlement.

21 Burg Simpson Attorneys Named to 2016 Best Lawyers® in America

 August 17, 2015

21 Burg Simpson Attorneys Named to 2016 Best Lawyers® in America

Denver, CO – Burg Simpson Eldredge Hersh & Jardine, P.C. is pleased to announce that 21 lawyers have been named to the 2016 Edition of Best Lawyers, one of the most respected peer review publications in the legal profession. The following attorneys were listed as 2016 “Lawyers of the Year” in various categories. Only a… Read more »

BURG SIMPSON ANNOUNCES $56.9 MILLION YAZ ARTERIAL THROMBOSIS SETTLEMENT

 August 5, 2015

BURG SIMPSON ANNOUNCES $56.9 MILLION YAZ ARTERIAL THROMBOSIS SETTLEMENT

Burg Simpson Eldredge Hersh & Jardine, P.C., announced Monday that Bayer HealthCare Pharmaceuticals Inc. (“Bayer”) has agreed to pay $56,900,000 to resolve the claims of approximately 1,300 women who suffered Arterial Thrombotic Events (“ATE”), such as strokes and heart attacks, after using Bayer’s drospirenone-containing oral contraceptives (Yaz, Yasmin, Ocella, Gianvi, Beyaz and Safyral) without admitting… Read more »

26 BURG SIMPSON ATTORNEYS FEATURED IN COLORADO SUPER LAWYERS MAGAZINE

 March 20, 2015

26 BURG SIMPSON ATTORNEYS FEATURED IN COLORADO SUPER LAWYERS MAGAZINE

DENVER, COLORADO – Burg Simpson is pleased to announce that 26 of the firm’s attorneys are featured in the 2015 edition of Colorado Super Lawyers® magazine. Shareholder David P. Hersh has been named a Colorado Top 10 Lawyer and shareholder Diane Vaksdal Smith has been named among Colorado’s Top 50 Women Lawyers. Further, shareholders Michael… Read more »

BURG SIMPSON LAUNCHES CONSUMER CLASS ACTION AS A RESULT OF DANGEROUS LEVELS OF INORGANIC ARSENIC IN CERTAIN CALIFORNIA WINES

 March 19, 2015

BURG SIMPSON LAUNCHES CONSUMER CLASS ACTION AS A RESULT OF DANGEROUS LEVELS OF INORGANIC ARSENIC IN CERTAIN CALIFORNIA WINES

Burg Simpson Eldredge Hersh & Jardine, PC has filed an important consumer class action in Los Angeles, California alleging that 83 different types of wine produced in California contain levels of inorganic arsenic that significantly exceed the level found to be acceptable by California, in some instances over five times the safe threshold. CBS News… Read more »

mylan-recalls-injectable-products-_188_40056909_0_14114882_300

 May 1, 2015

MYLAN RECALLS INJECTABLE PRODUCTS

According to the U.S. Food and Drug Administration, Mylan recalled injectable products due to the presence of a particulate matter. The nationwide recall involves hospital and user level products. A visible foreign particulate matter was observed during retention sample testing. Injectable products affected by the recall include Gemcitabine, Carboplatin, Methotrexate and Cytarabine injection. These injectable products came… Read more »

injection-solution-recalled-due-to-iron-oxide-particulate-contamination_188_40055190_0_14034981_300

 April 28, 2015

HOSPIRA RECALLS INJECTIONS DUE TO POSSIBLE IRON OXIDE CONTAMINATION

Pharmaceutical company Hospira, Inc. announced April 24 it was recalling one lot of its injection products: Preservative-Free Bupivacaine HCl Injection with a USP of 0.5 percent. The recall came after the company received one complaint of visible orange and black particles free floating and embedded in a single-dose vial of the product. The particles were identified… Read more »

testosterone-treatments-might-have-adverse-cardiovascular-risks_188_671053_0_14102841_300

 March 9, 2015

FDA: TESTOSTERONE THERAPY IS NOT APPROVED TO TREAT LOW TESTOSTERONE IN AGING MEN

On March 3, 2015, the FDA announced that it will require manufacturers of testosterone drugs to change their labels to notify patients and doctors that testosterone has not been tested or approved to treat low testosterone levels due to aging. Read the FDA’s March 3, 2015 Safety Announcement. Testosterone has Not Been Tested to Treat… Read more »

testosterone-treatments-might-have-adverse-cardiovascular-risks_188_671053_0_14102841_300

 March 6, 2015

FDA SAFETY ADVISORY: TESTOSTERONE DRUGS MAY INCREASE RISK OF HEART ATTACK AND STROKE

On March 3, 2015, the FDA announced that it will require manufacturers of testosterone replacement therapy products to update the drugs’ labeling to warn doctors and patients of a possible increased risk of heart attack and stroke associated with testosterone use. Read the FDA’s March 3, 2015 Safety Announcement. Prior to making this announcement, the… Read more »

janet-title2

 May 14, 2015

Depakote / Depakene (Valproic Acid) Can Have Life-Changing Side Effects

Mood-stabilizer and anti-epileptic and migraine medicines Depakote and Depakene (Valproic Acid) can affect cognitive development (lower IQ) and cause neuro-developmental delays (like autism) in children exposed to these medications while in utero. If your child was affected, you may be eligible for compensation. For more information, contact Burg Simpson lawyer Janet Abaray at 888-895-2080. See more… Read more »

yaz-danger

 May 14, 2015

What makes Yaz more dangerous than other birth control pills?

Yaz/Yasmin contain a chemical called drospirenone. Studies have shown that pills which contain drospirenone increase the risk of blood clots compared to other pills on the market.

yaz

 May 14, 2015

What are some side effects of Yaz?

Adverse effects of Yaz and Yasmin include blood clots, heart attacks and strokes.

Top 100 National Trial Lawyers Legal 500 Best Lawyers in America Super Lawyers US News 2014 US News 2014 Plantiffs Top 25 Most Influential Lawyers